IDENTI HEALTHCARE LTD |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 222.9 ILa | -1.20% |
|
+2.20% | -38.27% |
| Mar. 21 | Identi Healthcare Ltd Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 2023 | Identi Healthcare Ltd Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
Valuation
| Fiscal Period: December | 2021 | 2022 | 2023 |
|---|---|---|---|
| Capitalization 1 | 69.3 | 49.04 | 45.51 |
| Enterprise Value (EV) 1 | 49.65 | 36.59 | 39.62 |
| P/E ratio | -10.6 x | -6.83 x | -6.72 x |
| Yield | - | - | - |
| Capitalization / Revenue | 8.58 x | 5.19 x | 4.53 x |
| EV / Revenue | 8.58 x | 5.19 x | 4.53 x |
| EV / EBITDA | -11.7 x | -7.34 x | -6.58 x |
| EV / FCF | -53,343,582 x | -9,708,144 x | -11,437,044 x |
| FCF Yield | -0% | -0% | -0% |
| Price to Book | 3.1 x | 2.93 x | 4.25 x |
| Nbr of stocks (in thousands) | 12,600 | 12,603 | 12,603 |
| Reference price 2 | 5.500 | 3.891 | 3.611 |
| Announcement Date | 3/23/23 | 3/23/23 | 3/21/24 |
1ILS in Million2ILS
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 4.917 | 5.545 | 7.097 | 8.075 | 9.456 | 10.05 |
| EBITDA 1 | 0.246 | -3.138 | -0.433 | -5.922 | -6.677 | -6.917 |
| EBIT 1 | 0.23 | -3.154 | -0.452 | -5.989 | -6.75 | -7.008 |
| Operating Margin | 4.68% | -56.88% | -6.37% | -74.17% | -71.38% | -69.73% |
| Earnings before Tax (EBT) 1 | 0.164 | -3.293 | -0.584 | -6.009 | -6.596 | -6.777 |
| Net income 1 | 0.136 | -3.293 | -0.62 | -5.671 | -7.152 | -6.777 |
| Net margin | 2.77% | -59.39% | -8.74% | -70.23% | -75.63% | -67.43% |
| EPS 2 | 0.0151 | -0.3659 | -0.0689 | -0.5182 | -0.5700 | -0.5377 |
| Free Cash Flow | - | - | 0.1539 | -1.299 | -5.051 | -3.979 |
| FCF margin | - | - | 2.17% | -16.09% | -53.42% | -39.59% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 5/19/21 | 5/19/21 | 5/19/21 | 3/23/23 | 3/23/23 | 3/21/24 |
1ILS in Million2ILS
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt | - | 1.15 | 1.49 | - | - | - |
| Net Cash position | - | - | - | 19.6 | 12.4 | 5.89 |
| Leverage (Debt/EBITDA) | - | -0.3649 x | -3.436 x | - | - | - |
| Free Cash Flow | - | - | 0.15 | -1.3 | -5.05 | -3.98 |
| ROE (net income / shareholders' equity) | - | - | -519% | -50.4% | -36.5% | -49.4% |
| ROA (Net income/ Total Assets) | - | - | -9.05% | -25% | -17.8% | -24% |
| Assets 1 | - | - | 6.847 | 22.65 | 40.21 | 28.23 |
| Book Value Per Share | - | 0.0200 | 0.0100 | 1.780 | 1.330 | 0.8500 |
| Cash Flow per Share | - | 0.0100 | 0 | 1.020 | 0.4300 | 0.5300 |
| Capex | - | 0 | 0.42 | 0.04 | 0.02 | 0.27 |
| Capex / Sales | - | 0.04% | 5.85% | 0.45% | 0.22% | 2.66% |
| Announcement Date | 5/19/21 | 5/19/21 | 5/19/21 | 3/23/23 | 3/23/23 | 3/21/24 |
1ILS in Million
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
- Stock Market
- Equities
- IDNT Stock
- Financials Identi Healthcare Ltd